Clinical Trials Browser

Phase 2 × Melanoma × Interleukin-18 × Clear all

NCT00107718 2017-07-27

Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

Phase 2 Completed

Melanoma